Here are the latest quarterly results of MANKIND PHARMA. For more details, see the MANKIND PHARMA financial fact sheet and MANKIND PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|
Net Sales | Rs m | 20,527 | 25,786 | 27,081 | 26,070 | |
Other income | Rs m | 475 | 586 | 600 | 701 | |
Turnover | Rs m | 21,002 | 26,372 | 27,681 | 26,771 | |
Expenses | Rs m | 16,360 | 19,238 | 20,255 | 20,005 | |
Gross profit | Rs m | 4,167 | 6,548 | 6,826 | 6,065 | |
Depreciation | Rs m | 845 | 874 | 965 | 1,097 | |
Interest | Rs m | 52 | 63 | 86 | 92 | |
Profit before tax | Rs m | 3,745 | 6,197 | 6,375 | 5,577 | |
Tax | Rs m | 836 | 1,303 | 1,298 | 1,025 | |
Profit after tax | Rs m | 2,909 | 4,895 | 5,077 | 4,552 | |
Gross profit margin | % | 20.3 | 25.4 | 25.2 | 23.3 | |
Effective tax rate | % | 22.3 | 21.0 | 20.4 | 18.4 | |
Net profit margin | % | 14.2 | 19.0 | 18.7 | 17.5 | |
Diluted EPS | Rs | 7.3 | 12.2 | 12.7 | 11.4 | |
Diluted EPS (TTM) | Rs | NA | NA | NA | 43.5 | |
Subscriber Feature |
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.